Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Change in Cash (2020 - 2025)

Agilon Health (AGL) has disclosed Change in Cash for 6 consecutive years, with $2.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Cash fell 94.94% year-over-year to $2.0 million, compared with a TTM value of -$20.1 million through Dec 2025, down 125.33%, and an annual FY2025 reading of -$20.1 million, down 125.33% over the prior year.
  • Change in Cash was $2.0 million for Q4 2025 at Agilon Health, up from $268000.0 in the prior quarter.
  • Across five years, Change in Cash topped out at $1.0 billion in Q2 2021 and bottomed at -$352.6 million in Q2 2022.
  • Average Change in Cash over 5 years is $1.7 million, with a median of -$21.1 million recorded in 2021.
  • The sharpest move saw Change in Cash skyrocketed 12858.01% in 2021, then tumbled 1408.62% in 2025.
  • Year by year, Change in Cash stood at -$41.1 million in 2021, then tumbled by 38.25% to -$56.8 million in 2022, then fell by 13.05% to -$64.2 million in 2023, then soared by 162.4% to $40.1 million in 2024, then crashed by 94.94% to $2.0 million in 2025.
  • Business Quant data shows Change in Cash for AGL at $2.0 million in Q4 2025, $268000.0 in Q3 2025, and $32.8 million in Q2 2025.